Clinical Evaluation of Patients with Mixed Low-and-High Grade Non-muscle Invasive Bladder Cancer with EORTC Risk Scores
Tianjie Lan(Linyi People's Hospital), Gang Li(Linyi People's Hospital), Gaoteng Lin(First Affiliated Hospital of Jinan University), Yuhong Li(Southwest Jiaotong University), Xiaoming Wang(Linyi People's Hospital), Chuanfeng Liu(Qingdao University), Yi Lu(Shandong Provincial Hospital), Yuanjie Niu
Cited by 0
Related Papers
The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor–Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy—MONARCH 2
|JAMA Oncology|2019|1k
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma
|New England Journal of Medicine|2019|934
Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial
|Nature Medicine|2024|162